platinum has been researched along with ribose in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Boiwe, T; Brändén, CI; Eklund, H; Nordström, B; Ohlsson, I; Söderlund, G; Zeppezauer, E | 1 |
| Gunnarsson, PO; Pettersson, G; Zeppezauer, M | 1 |
| Ainsworth, B; Ammar, A; Ellis, PA; Pakozdi, T; Ramathal, CY; Riley-Gillis, B; Stolzenburg, LR; Wilsbacher, JL | 1 |
| Arenare, L; Baldassarre, G; Bartoletti, M; Califano, D; Capoluongo, E; Chiodini, P; Costi, MP; D'Incalci, M; Greggi, S; Marchini, S; Mezzanzanica, D; Musacchio, L; Normanno, N; Perrone, F; Pignata, S; Scala, S; Schettino, C | 1 |
| Hirata, M; Ishikawa, M; Noguchi, E; Odaka, Y; Saito, A; Shimoi, T; Sudo, K; Tanioka, M; Watanabe, T; Yonemori, K | 1 |
| Bu, H; Feng, S; Huang, Y; Jin, C; Kong, B; Li, N; Liu, J; Ma, Y; Song, K; Wen, H; Wu, L; Yang, X; Zhang, H | 1 |
6 other study(ies) available for platinum and ribose
| Article | Year |
|---|---|
The structure of horse liver alcohol dehydrogenase.
Topics: Adenosine; Alcohol Oxidoreductases; Animals; Binding Sites; Computers; Cyanides; Glyceraldehyde-3-Phosphate Dehydrogenases; Guanidines; Horses; Hot Temperature; L-Lactate Dehydrogenase; Liver; Models, Molecular; Nucleoside Diphosphate Sugars; Platinum; Protein Binding; Protein Conformation; Ribose; Salicylates; Temperature; X-Ray Diffraction | 1974 |
Inhibition of horse-liver alcohol dehydrogenase by Pt(CN)4 2- and Au(CN)2-.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Alcohol Oxidoreductases; Amino Acid Sequence; Animals; Arginine; Binding Sites; Cyanides; Gold; Horses; Iodoacetates; Kinetics; Liver; Nucleoside Diphosphate Sugars; Phenanthrolines; Platinum; Ribose | 1974 |
Transcriptomics reveals
Topics: Adenosine Diphosphate; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cholesterol; Cisplatin; Humans; Integrins; Lung Neoplasms; Platinum; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Ribose; Transcriptome; Transforming Growth Factor beta | 2022 |
Olaparib beyond progression compared with platinum chemotherapy after secondary cytoreductive surgery in patients with recurrent ovarian cancer: phase III randomized, open-label MITO 35b study, a project of the MITO-MANGO groups.
Topics: Adenosine Diphosphate; Antineoplastic Agents; Carcinoma, Ovarian Epithelial; Cytoreduction Surgical Procedures; Female; Humans; Mangifera; Neoplasm Recurrence, Local; Ovarian Neoplasms; Phthalazines; Piperazines; Platinum; Poly(ADP-ribose) Polymerase Inhibitors; Ribose | 2022 |
Case report: Response to platinum agents and poly (adenosine diphosphate-ribose) polymerase inhibitor in a patient with BRCA1 c.5096G>A (R1699Q) intermediate-risk variant.
Topics: Adenosine Diphosphate; Aged; BRCA1 Protein; Female; Humans; Ovarian Neoplasms; Peritoneal Neoplasms; Platinum; Poly(ADP-ribose) Polymerase Inhibitors; Ribose | 2022 |
Efficacy of poly (ADP-ribose) polymerase inhibitors monotherapy and the impact to subsequent platinum-based chemotherapy in breast cancer susceptibility genes1/2-mutated ovarian cancer patients with secondary platinum-sensitive relapse.
Topics: BRCA1 Protein; BRCA2 Protein; Breast Neoplasms; Carcinoma, Ovarian Epithelial; Disease Progression; Female; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Platinum; Poly(ADP-ribose) Polymerase Inhibitors; Recurrence; Retrospective Studies; Ribose | 2023 |